news
Asterias collaborates with Cell Therapy Catapult to scale production of AST-VAC2
13 October 2015 | By Victoria White
AST-VAC2 is an immunotherapy product that contains mature dendritic cells derived from pluripotent stem cells...
List view / Grid view
Gene Therapy
Gene Therapy is the introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders.
news
Gene therapy prevents disease effects in Parkinson’s disease model
9 October 2015 | By Victoria White
Researchers reported that treatment with IFNβ-gene therapy successfully prevented neuronal death and disease effects in an experimental model of the disease...
news
Cell Therapy Catapult launches the Cell History File
7 October 2015 | By Victoria White
The Cell History File has been designed to fulfil the role of a ‘cell passport’ that can accompany a tissue or cell derived product as it progresses through various processing stages...
news
Gene therapy shows success in vision loss mitochondrial disease
6 October 2015 | By Victoria White
Researchers have found that they can use gene therapy to improve visual in mice models for the vision disorder Leber hereditary optic neuropathy (LHON)...
article
Microfluidic technology: the next-generation drug discovery tool
Microfluidic miniaturisation, or the so-called ‘lab-on-a-chip’ concept, now encroaches on the fields of biology, medicine and pharmacology, and the nature of microfluidic technology (small volumes and high-throughput integration of fluid connections) means that it is outperforming conventional bench work. There has been an incredible need for microfluidic technology in the…
news
Scientists create immunity to E. histolytica by silencing genes
17 September 2015 | By Victoria White
The new technique could be used to explore genetic mechanisms of resistance in the field of infectious disease and lead to new therapies...
news
CEVEC and Généthon to develop lentivirus packaging cell lines
17 September 2015 | By Victoria White
CEVEC is to grant Généthon a license for the development of lentivirus packaging cell lines based on CEVEC’s CAP GT technology...
news
Genetic testing reveals new drug targets in oesophageal cancer
2 September 2015 | By Victoria White
Nearly all advanced oesophageal cancers harbour genetic mutations that can be targeted with emerging drug therapies, according to a new study...
news
Nerve growth factor triggers functional cell growth in Alzheimer’s disease
28 August 2015 | By Victoria White
Degenerating neurons in patients with Alzheimer's disease measurably responded to a gene therapy in which nerve growth factor was injected into their brains...
news
Research suggests ion channel blocking drugs could be used in cancer therapy
12 August 2015 | By Author: Katie Sadler, Digital Content Producer, Drug Target Review
Research carried out by University of California San Francisco (UCSF) has revealed ion channel blocking drugs could play a part in cancer therapy. The common class of channel blocking drugs, which are used to treat cardiac, neurological, and psychiatric disorders, could prove to be beneficial in cancer treatment according to…
news
Nanoparticles used to breach lung mucus barrier
4 August 2015 | By Victoria White
Researchers have used nanoparticles to breach the human airway mucus barrier of lung tissue - a finding that could lead to effective drug delivery systems...
news
Researchers resurrect ancient virus to improve gene therapy
31 July 2015 | By Victoria White
Researchers have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina...
news
UMG and MRC Technology collaborate to develop Alzheimer’s therapy
28 July 2015 | By Victoria White
UMG and MRC Technology are to collaborate to develop a novel therapy for neurodegenerative diseases based on antibody targeting amyloid beta peptides 4-x...
news
Regeneron and Sanofi launch major immuno-oncology collaboration
28 July 2015 | By Victoria White
Regeneron and Sanofi have entered into a new global collaboration to discover, develop and commercialise new antibody cancer treatments in immuno-oncology...
news
UCLA scientists discover therapy that can suppress ulcerative colitis
24 July 2015 | By Victoria White
UCLA scientists have discovered a microRNA-214 inhibitor that has the ability to suppress the development of ulcerative colitis...